Company

Red Arrow Therapeutics, Inc.

Red Arrow Therapeutics develops nanotechnology-based drug delivery systems for cancer treatment.

About

Red Arrow Therapeutics develops nanotechnology-based treatments for patients with cancer. Its pipeline includes nanopolymer cytokine micelles and treatments intended to convert cold tumors to hot. Founded in 2021, the company is based in Tokyo, Japan. It raised JPY 700 million in seed funding in April 2024.

1Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in